Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma Proteomics Elucidated a Protein Signature in COVID-19 Patients with Comorbidities and Early-Diagnosis Biomarkers. | Biomedicines | 2024 | 38672194 | PubTator, text mining | PubMed |
| RNA therapeutics to control fibrinolysis: review on applications in biology and medicine. | J Thromb Haemost | 2024 | 38663489 | PubTator, text mining | PubMed |
| The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation. | Cells | 2024 | 38534360 | PubTator, text mining | PubMed |
| Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity. | J Thromb Thrombolysis | 2024 | 38523179 | PubTator, text mining | PubMed |
| Omics data analysis reveals the system-level constraint on cellular amino acid composition. | Synth Syst Biotechnol | 2024 | 38510205 | PubTator, text mining | PubMed |
| Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype. | Res Pract Thromb Haemost | 2024 | 38487678 | PubTator, text mining | PubMed |
| A novel method to quantify fibrin-fibrin and fibrin-α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma. | J Thromb Haemost | 2024 | 38462220 | PubTator, text mining | PubMed |
| The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study. | Lancet Oncol | 2024 | 38346438 | PubTator, text mining | PubMed |
| Prognostic value of coagulation markers in patients with colorectal caner: A prospective study. | Health Sci Rep | 2024 | 38304067 | PubTator, text mining | PubMed |
| Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial. | Res Pract Thromb Haemost | 2024 | 38292350 | PubTator, text mining | PubMed |
| Chemical Adjustment of Fibrinolysis. | Pharmaceuticals (Basel) | 2024 | 38256925 | PubTator, text mining | PubMed |
| Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. | Med Sci (Basel) | 2024 | 38249080 | PubTator, text mining | PubMed |
| Hemostatic Profile of Intrauterine Growth-Restricted Neonates: Assessment with the Use of NATEM Assay in Cord Blood Samples. | Diagnostics (Basel) | 2024 | 38248055 | PubTator, text mining | PubMed |
| Association between ethylene oxide exposure and periodontitis: a cross-sectional study from NHANES 2013-2014. | BMC Public Health | 2024 | 38229065 | PubTator, text mining | PubMed |
| Fluorescent peptide for detecting factor XIIIa activity and fibrin in whole blood clots forming under flow. | Res Pract Thromb Haemost | 2024 | 38222077 | PubTator, text mining | PubMed |
| Prognostic model to predict the incidence of radiographic knee osteoarthritis. | Ann Rheum Dis | 2024 | 38182405 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells. | Oncogenesis | 2024 | 38177125 | PubTator, text mining | PubMed |
| A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene. | Thromb J | 2024 | 38169400 | PubTator, text mining | PubMed |
| Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption. | Sci Rep | 2024 | 38168649 | PubTator, text mining | PubMed |
| Replenishing the physician-scientist pipeline in the post-late bloomer era. | J Clin Invest | 2024 | 38165045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=9